Stem cell research

Journal of cancer research and clinical oncology

[1] CD44 splice variant (CD44v3) promotes progression of urothelial carcinoma of bladder through Akt/ERK/STAT3 pathways: novel therapeutic approach.

[2] The primary cilium directs osteopontin-induced migration of mesenchymal stem cells by regulating CD44 signaling and Cdc42 activation.

[3] Establishment of SIAISi002-A, an induced pluripotent stem cell (iPSC) line from 39-year old healthy female donor with a family history of Alzheimer's disease (AD) and two copies of APOE4 gene.

[4] antibody-modified liposomes for tumor-targeting delivery of timosaponin aiii

[5] cd44 on blood eosinophils as a novel marker of bronchial asthma management

[6] fibrocytes in the fibrotic lung: altered phenotype detected by flow cytometry

[7] positive expression of kif20a indicates poor prognosis of glioma patients

[8] avaliação da imunomarcação de células-tronco tumorais em carcinossarcomas mamários e carcinomas em tumores mistos em cadelas

[9] cd44/cd44v6 a reliable companion in cancer-initiating cell maintenance and tumor progression

[10] monitoring and inhibiting mt1-mmp during cancer initiation and progression

[11] CD44 targeted delivery of siRNA by using HA-decorated nanotechnologies for KRAS silencing in cancer treatment.

[12] Receptor-Meditated Endocytosis by Hyaluronic Acid@Superparamagnetic Nanovetor for Targeting of CD44-Overexpressing Tumor Cells

[13] CD44 splice variant (CD44v3) promotes progression of urothelial carcinoma of bladder through Akt/ERK/STAT3 pathways: novel therapeutic approach.

[14] CD44 expression in renal ischemia-reperfusion injury in rats.

[15] CD44 targeted redox-triggered self-assembly with magnetic enhanced EPR effects for effective amplification of gambogic acid to treat triple-negative breast cancer.

[16] Single Cell Mass Cytometry Revealed the Immunomodulatory Effect of Cisplatin Via Downregulation of Splenic CD44+, IL-17A+ MDSCs and Promotion of Circulating IFN-γ+ Myeloid Cells in the 4T1 Metastatic Breast Cancer Model.

[17] Facile Strategy by Hyaluronic Acid Functional Carbon Dot-Doxorubicin Nanoparticles for CD44 Targeted Drug Delivery and Enhanced Breast Cancer Therapy.

[18] The primary cilium directs osteopontin-induced migration of mesenchymal stem cells by regulating CD44 signaling and Cdc42 activation.

[19] Renal carcinoma CD105−/CD44− cells display stem-like properties in vitro and form aggressive tumors in vivo

[20] pancd44 immunohistochemical evaluation in prostatectomies from patients with adenocarcinoma

[21] cd44 on blood eosinophils as a novel marker of bronchial asthma management

[22] critical role of cd44 in antigen-induced th2- but not th17-madiated murine airway inflammation

[23] quantitative immunohistochemical analyses of the expression of e-cadherin, thrombomodulin, cd44h and cd44v6 in primary tumours of pharynx/larynx squamous cell carcinoma and their lymph node metastases

[24] cd44/cd44v6 a reliable companion in cancer-initiating cell maintenance and tumor progression

[25] initiation and maintenance of gastric cancer: a focus on cd44 variant isoforms and cancer stem cellssummary

[26] cd44 gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathologic features

[27] Role of CD44 in the organization of keratinocyte pericellular hyaluronan.

[28] Co-downregulation of cell adhesion proteins alpha- and beta-catenins, p120CTN, E-cadherin, and CD44 in prostatic adenocarcinomas